- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2013-12
2022-04-14
2024-06
2325
NCT02089269
iOMEDICO AG
iOMEDICO AG
OBSERVATIONAL
Tumor Registry Pancreatic Cancer
The registry aims to collect and analyse information on the antineoplastic treatment of patients with unresectable locally advanced or metastatic pancreatic cancer, treated in palliative intention (cohort 1) and patients with localized, resectable pancreatic cancer treated in neo-adjuvant or adjuvant intention (cohort 2) in daily routine practice in Germany. The registry will follow up patients for two years. It will identify common sequences of treatments used as well as changes in the treatment of the disease. Health-related quality of life will be analysed during the course of the treatment (PanLife). Based on the available data a prognostic score will be developed.
N/A
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2014-03-14 | N/A | 2025-01-28 |
2014-03-14 | N/A | 2025-01-30 |
2014-03-17 | N/A | 2024-10 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
N/A
Allocation:
N/A
Interventional Model:
N/A
Masking:
N/A
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| : Cohort 1 2,200 patients with unresectable locally advanced or metastatic pancreatic cancer, treated in palliative intention | |
| : Cohort 2 125 patients with localized, resectable pancreatic cancer treated in neo-adjuvant or adjuvant intention |
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Treatment reality in Germany | description of treatments selected for patients per line of therapy over the course of the project | over 5 years |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
